Current role
Johanna Friedl-Naderer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Dyne Therapeutics, Inc. (DYN)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | $610,691 | $1,086,420 |
| 2024 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | $171,164 | $8,190,480 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.